Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00714753 · ClinicalTrials.gov registry record · Phase 2
Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT00714753: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT00714753 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00714753, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
RATIONALE: Internal radiation uses radioactive material placed directly into or near a tumor to kill tumor cells. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase II trial is studying the side effects of internal radiation therapy when given with or without external-beam radiation therapy and to see how well it works in treating patients with localized prostate cancer.
Interventions
- RADIATION intensity-modulated radiation therapy
- RADIATION brachytherapy
- RADIATION hypofractionated radiation therapy
- RADIATION image-guided radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2008-08 |
| Est. Completion | 2013-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00714753
The ClinicalTrials.gov registry entry for NCT00714753 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which intensity-modulated radiation therapy is the first listed.
NCT00714753 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00714753 about?
NCT00714753 is a clinical study titled "Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer". RATIONALE: Internal radiation uses radioactive material placed directly into or near a tumor to kill tumor cells. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase II trial...
What is the current status of trial NCT00714753?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2008-08. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00714753?
The interventions under investigation include: intensity-modulated radiation therapy (RADIATION), brachytherapy (RADIATION), hypofractionated radiation therapy (RADIATION), image-guided radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT00714753?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.